Hitherto unseen survival in an ALK-positive-patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Hitherto unseen survival in an ALK-positive-patient withadvanced stage adult ganglioneuroblastoma treated withpersonalized medicine
Final published version, 65.7 KB, PDF document
Survival of stage 4 ganglioneuroblastoma (GNB) patients is poor; no reports exist of patients surviving up to 5 years (1, 2). We report the clinical and therapeutic course of a patient with stage 4 GNB surviving beyond expectations due to a multimodal treatment approach incorporating new technologies in cancer diagnostic and treatment.
| Original language | English |
|---|---|
| Journal | Clinical Case Reports |
| Volume | 5 |
| Issue number | 12 |
| Pages (from-to) | 2085-2087 |
| Number of pages | 3 |
| ISSN | 2050-0904 |
| DOIs | |
| Publication status | Published - Dec 2017 |
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available
ID: 196371326